Neves, AA;
Xie, B;
Fawcett, S;
Alam, IS;
Witney, TH;
de Backer, MM;
Summers, J;
... Brindle, KM; + view all
(2017)
Rapid Imaging of Tumor Cell Death In Vivo Using the C2A Domain of Synaptotagmin-I.
Journal of Nuclear Medicine
, 58
(6)
pp. 881-887.
10.2967/jnumed.116.183004.
Preview |
Text
J Nucl Med-2017-Neves-jnumed.116.183004.pdf - Accepted Version Download (3MB) | Preview |
Abstract
Cell death is an important target for imaging the early response of tumors to treatment. We describe here the validation of a phosphatidylserine-binding agent for detecting tumor cell death in vivo based on the C2A domain of synaptotagmin-I. Methods: The capability of near-infrared fluorophore-labeled and 99mTc- and 111In-labeled derivatives of C2Am for imaging tumor cell death, using planar near-infrared fluorescence imaging and SPECT, respectively, was evaluated in implanted and genetically engineered mouse models of lymphoma and in a human colorectal xenograft. Results: The fluorophore-labeled C2Am derivative showed predominantly renal clearance and high specificity and sensitivity for detecting low levels of tumor cell death (2%–5%). There was a significant correlation (R > 0.9, P < 0.05) between fluorescently labeled C2Am binding and histologic markers of cell death, including cleaved caspase-3, whereas there was no such correlation with a site-directed mutant of C2Am (iC2Am) that does not bind phosphatidylserine. 99mTc-C2Am and 111In-C2Am also showed favorable biodistribution profiles, with predominantly renal clearance and low nonspecific retention in the liver and spleen at 24 h after probe administration. 99mTc-C2Am and 111In-C2Am generated tumor-to-muscle ratios in drug-treated tumors of 4.3× and 2.2×, respectively, at 2 h and 7.3× and 4.1×, respectively, at 24 h after administration. Conclusion: Given the favorable biodistribution profile of 99mTc- and 111In-labeled C2Am, and their ability to produce rapid and cell death–specific image contrast, these agents have potential for clinical translation.
| Type: | Article |
|---|---|
| Title: | Rapid Imaging of Tumor Cell Death In Vivo Using the C2A Domain of Synaptotagmin-I |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.2967/jnumed.116.183004 |
| Publisher version: | http://dx.doi.org/10.2967/jnumed.116.183004 |
| Language: | English |
| Additional information: | This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Radiology, Nuclear Medicine & Medical Imaging, cell death, C2A, synaptotagmin, imaging, mouse, tumor, TARGETED CONTRAST AGENT, ANNEXIN-V, PET TRACER, APOPTOSIS, TC-99M, CHEMOTHERAPY, CANCER, BIOMARKERS, F-18-ML-10, DOSIMETRY |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Experimental and Translational Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10049462 |
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
